| Absorption | 
      | Blood-Brain Barrier | BBB- | 0.9907 | 
      | Human Intestinal Absorption | HIA- | 0.9382 | 
      | Caco-2 Permeability | Caco2- | 0.8252 | 
      | P-glycoprotein Substrate | Non-substrate | 0.5483 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.9086 | 
                                                     | Non-inhibitor | 0.9861 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.9670 | 
        
            | Distribution | 
        
      | Subcellular localization | Lysosome | 0.4958 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8103 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8492 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.5695 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.9066 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9208 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9336 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9212 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.9268 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9896 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9998 | 
                                                                    | Non-inhibitor | 0.9284 | 
      | AMES Toxicity | Non AMES toxic | 0.8670 | 
      | Carcinogens | Non-carcinogens | 0.6071 | 
      | Fish Toxicity | High FHMT | 0.7790 | 
      | Tetrahymena Pyriformis Toxicity | Low TPT | 0.6931 | 
      | Honey Bee Toxicity | Low HBT | 0.6705 | 
      | Biodegradation | Not ready biodegradable | 0.9654 | 
      | Acute Oral Toxicity | IV | 0.6254 | 
      | Carcinogenicity (Three-class) | Non-required | 0.6620 |